Intrepid Financial Planning Group »

Cara Therapeutics shares owned by Intrepid Financial Planning Group

Quarter-by-quarter ownership of Cara Therapeutics (CARA) shares owned by Intrepid Financial Planning Group from 13F filings

Historical chart of Intrepid Financial Planning Group investment in Cara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cara Therapeutics held by Intrepid Financial Planning Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cara Therapeutics by Intrepid Financial Planning Group

Quarter filed Position value Share count Share price at filing
2023-09-30 $19k 12k 1.68
2023-06-30 $33k 12k 2.83
2023-03-31 $57k 12k 4.91
2022-12-31 $124k 12k 10.74
2022-09-30 $136k 15k 9.38
2022-06-30 $132k 15k 9.10

More positions owned by Intrepid Financial Planning Group

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Exch Traded Fd Tr Ii Pfd Etf (PGX)
Ishares Tr Rus 1000 Grw Etf (IWF)
Apple (AAPL)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Select Sector Spdr Tr Technology (XLK)
Eli Lilly & Co. (LLY)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Select Sector Spdr Tr Energy (XLE)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Ishares U S Etf Tr Bloomberg Roll (CMDY)
JPMorgan Chase & Co. (JPM)
Northwest Bancshares (NWBI)
Select Sector Spdr Tr Indl (XLI)

View all positions for Intrepid Financial Planning Group

Top funds holding Cara Therapeutics

Vanguard Group
Chescapmanager
Rosalind Advisors
Federated Investors
AQR Capital Management
Jacobs Levy Equity Management
Bank of America Corporation
Two Sigma Advisers
Millennium Management
Stifel Financial
Two Sigma Investments
Bnp Paribas Arbitrage, Snc
Charles Schwab Investment Management
GSA Capital Partners
Goldman Sachs Group

View all funds holding Cara Therapeutics